Day: January 5, 2022

Calgary, Alberta, Jan. 05, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Forza Innovations Inc. (OTC Pink: FORZ) (the “Company”) is pleased to announce the appointment of Johnny Ku as a Senior International Consultant within the international manufacturing and logistics segment of Forza Innovations Inc. Mr. Ku is joining the company with over 10 years of experience in strategic global sourcing. Johnny began his career working in the family business of home decor and kitchenware (ceramic, metal & glass), later branching into the fashion industry, including shoes, bags, hats and clothing.  Johnny has been doing sourcing, product development and monitoring mass production for a variety of global corporations including Bath & Body Works, Victoria’s Secret, PINK, Peet’s Coffee, Starbucks, KITH, Nike, Adidas, Katy...

Riot produces 425 Bitcoin in December 2021 and 3,812 Bitcoin in 2021, Executes Multiple Miner Purchase Agreements and Increases Self-Mining Hash Rate Capacity to 12.8 EH/s for 2022Riot is increasing its 2022 estimated hash rate capacity by 3.8 EH/s to 12.8 EH/s, representing a 42% increase over the Company’s previously announced estimate of 9.0 EH/s.By Q4 2022, Riot anticipates a total self-mining hash rate capacity of 12.8 EH/s, assuming full deployment of approximately 120,150 Antminer ASICs, but excluding any potential expected incremental productivity gains from the Company’s utilization of 200 MW of immersion-cooling infrastructure.In December 2021, Riot completed Building F, the Company’s first industrial-scale immersion-cooled dedicated building, in addition to receiving most of the structural components required...

FREMONT, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) — Corsair Gaming, Inc. (NASDAQ:CRSR) (“Corsair”), a leading global provider and innovator of high-performance gear for gamers and content creators, today announced it has appointed Thi La and Sarah Mears Kim to its Board of Directors, effective as of December 29, 2021. Ms. La has served as Corsair’s President since January 2021 and as its Chief Operating Officer since August 2013. From May 2010 to August 2013, she served as Corsair’s Senior Vice President and General Manager of the gaming PC component unit. Previously, from April 2008 to July 2010, Ms. La served as the Vice President of Global Operations and Information Technology at Opnext, Inc., a designer and manufacturer of optical transponders for communications uses. From 1997 to 2008 she held various positions at HP, including...

TULSA, OK, Jan. 05, 2022 (GLOBE NEWSWIRE) — Laredo Petroleum, Inc. (NYSE: LPI) (“Laredo” or the “Company”) will report fourth-quarter 2021 financial and operating results after the market close on Tuesday, February 22, 2022, and will host a conference call on Wednesday, February 23, 2022, at 7:30 a.m. CT to discuss the results. To participate on the call, dial 877.930.8286 (international dial-in 253.336.8309), using conference code 3342479 or listen to the call via the Company’s website at www.laredopetro.com, under the tab for “Investor Relations.” A telephonic replay will be available approximately two hours after the call by dialing 855.859.2056, using conference code 3342479. About Laredo Laredo Petroleum, Inc. is an independent energy company with headquarters in Tulsa, Oklahoma. Laredo’s...

RAPID CITY, S.D., Jan. 05, 2022 (GLOBE NEWSWIRE) — Black Hills Corp. (NYSE: BKH) today announced that in December its natural gas utility subsidiaries in Colorado, Iowa and Kansas, doing business as Black Hills Energy, received final approvals for their separately filed rate reviews to recover investments made in natural gas infrastructure systems in their respective states. “These approvals complete our three 2021 strategic rate review regulatory initiatives,” said Linn Evans, president and CEO. “Concluding these rate reviews allows us to continue investing in safe and reliable service for our customers while supporting the growth of local communities in Colorado, Iowa and Kansas.” Black Hills Colorado Gas Black Hills Colorado Gas, Inc.’s settlement agreement was effective Dec. 13 after approval by operation of law following the...

EDISON, N.J., Jan. 05, 2022 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic drug development for the treatment of non-alcoholic steatohepatitis (“NASH”) and other liver diseases, today announced that it will participate in the H.C. Wainwright BioConnect Conference, to be held virtually January 10-13, 2022. Hepion’s pre-recorded presentation will be available on demand during the event for all registered attendees. Beginning on Monday, January 10, 2022, the presentation will also be available on the Company’s website at www.hepionpharma.com under “Events” in the “Investors” section. About Hepion Pharmaceuticals The Company’s lead drug candidate, CRV431, is a potent inhibitor of cyclophilins, which...

Acquisition Extends AMC Networks’ Position as the Global Leader in Targeted Streaming, with an Expanding Array of Services that Super-Serve Passionate Fans NEW YORK, Jan. 05, 2022 (GLOBE NEWSWIRE) — AMC Networks Inc. (NASDAQ: AMCX) announced today it has completed the acquisition of Houston-based Sentai Holdings, LLC (“Sentai”), a leading global supplier of anime content and official anime merchandise, with brands including the anime-focused HIDIVE direct-to-consumer subscription streaming service. The acquisition includes all of the member interests from Cool Japan Fund, Inc., a public-private Japanese investment fund. With strong industry relationships and access to key content creators in Japan, Sentai distributes and curates one of the anime industry’s most diverse libraries of top trending and classic titles, with its content...

Roivant will develop RVT-2001 for the treatment of transfusion-dependent anemia in patients with lower-risk myelodysplastic syndromes Roivant JPM presentation scheduled for Monday, January 10, at 2:15 p.m. ETBASEL, Switzerland and LONDON and NEW YORK and BOSTON, Jan. 05, 2022 (GLOBE NEWSWIRE) — Roivant Sciences (Nasdaq: ROIV), a next-generation biopharmaceutical company dedicated to improving the delivery of healthcare to patients, today announced that it has entered into a licensing agreement with Eisai Co., Ltd. for exclusive global rights to the investigational agent RVT-2001 (also known as H3B-8800), which will provide the lead program for a new subsidiary Vant. RVT-2001 is an orally available small molecule modulator of splicing factor 3B subunit 1 (SF3B1) with over 80 human subjects exposed to date. Under the terms of...